Literature DB >> 10867651

Angiogenesis inhibition by transdominant mutant Ets-1.

T Nakano1, M Abe, K Tanaka, R Shineha, S Satomi, Y Sato.   

Abstract

The expression of transcription factor Ets-1 is induced in endothelial cells (ECs) by angiogenic factor; and in turn Ets-1 converts ECs to angiogenic invasive phenotype. In order to control angiogenesis, we constructed a transdominant mutant Ets-1 (TMEts-1) which acts as a dominant negative molecule. This molecule inhibited the DNA binding and the transactivation activity of the wild-type Ets-1. Stable transfection of murine endothelial cell line MSS31 cells with the TMets-1 gene impaired angiogenic activities including proliferation, migration, invasion, and tube formation in type-1 collagen gel. Finally, we incorporated the TMets-1 gene into a non-proliferative adenovirus vector, designated as AdTMets-1. AdTMets-1 significantly inhibited angiogenesis in the Matrigel plugs injected into the subcutaneous tissue of C57BL mice. These results indicate that TMets-1 would be a tool for angiogenic inhibition. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10867651     DOI: 10.1002/1097-4652(200008)184:2<255::AID-JCP14>3.0.CO;2-J

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  22 in total

1.  Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells.

Authors:  Dakang Xu; Trevor J Wilson; David Chan; Elisabetta De Luca; Jiong Zhou; Paul J Hertzog; Ismail Kola
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

2.  Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis.

Authors:  Xuling Huang; Courtney Brown; Weihua Ni; Elizabeth Maynard; Alan C Rigby; Peter Oettgen
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

3.  Combinatorial function of ETS transcription factors in the developing vasculature.

Authors:  Van N Pham; Nathan D Lawson; Joshua W Mugford; Louis Dye; Daniel Castranova; Brigid Lo; Brant M Weinstein
Journal:  Dev Biol       Date:  2006-10-25       Impact factor: 3.582

Review 4.  Vascular development in the zebrafish.

Authors:  Aniket V Gore; Kathryn Monzo; Young R Cha; Weijun Pan; Brant M Weinstein
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

Review 5.  Regulation of endothelial cell development by ETS transcription factors.

Authors:  Stryder M Meadows; Candace T Myers; Paul A Krieg
Journal:  Semin Cell Dev Biol       Date:  2011-09-18       Impact factor: 7.727

6.  Transcriptional silencing of the ETS1 oncogene contributes to human granulocytic differentiation.

Authors:  Valentina Lulli; Paolo Romania; Roberta Riccioni; Alessandra Boe; Francesco Lo-Coco; Ugo Testa; Giovanna Marziali
Journal:  Haematologica       Date:  2010-04-30       Impact factor: 9.941

7.  The transcription factor ETS-1 mediates proinflammatory responses and neointima formation in carotid artery endoluminal vascular injury.

Authors:  Wenguang Feng; Dongqi Xing; Ping Hua; Yun Zhang; Yiu-Fai Chen; Suzanne Oparil; Edgar A Jaimes
Journal:  Hypertension       Date:  2010-04-05       Impact factor: 10.190

8.  Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling.

Authors:  Yumei Zhan; Courtney Brown; Elizabeth Maynard; Aleksandra Anshelevich; Weihua Ni; I-Cheng Ho; Peter Oettgen
Journal:  J Clin Invest       Date:  2005-09       Impact factor: 14.808

9.  Blockade of Ets-1 attenuates epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells.

Authors:  Velidi H Rao; Vikrant Rai; Samantha Stoupa; Devendra K Agrawal
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-07       Impact factor: 4.733

10.  Transcription factor Ets-1 mediates ischemia- and vascular endothelial growth factor-dependent retinal neovascularization.

Authors:  Daisuke Watanabe; Hitoshi Takagi; Kiyoshi Suzuma; Izumi Suzuma; Hideyasu Oh; Hirokazu Ohashi; Seiji Kemmochi; Akiyoshi Uemura; Tomonari Ojima; Eri Suganami; Noriko Miyamoto; Yasufumi Sato; Yoshihito Honda
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.